Analyst Desks Fan Out Across Biotech and Consumer as China Auto Demand Cracks
A heavy slate of target revisions from Guggenheim, Canaccord and UBS spans oncology, energy and household products, even as a 20% collapse in Chinese passenger vehicle retail sales flags a genuine demand shock in the world's largest auto market.
Sell-side research activity clustered in clinical-stage biotech and consumer discretionary names, with upgrades for ConocoPhillips, SharkNinja, BridgeBio and Cogent offset by reductions at Middleby and Neurogene. The sharper signal came from China, where July passenger vehicle retail sales fell 20% year over year.
BREAKING STORYBEARISH